Picture of Zomedica logo

ZOM Zomedica Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m+28.65%
3m+35.1%
6m-14.51%
1yr-26.56%
Volume Change (%)
10d/3m+81.39%
Price vs... (%)
52w High-28.16%
50d MA+20.88%
200d MA+9.83%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-19.58%
Return on Equity-15.07%
Operating Margin-177.72%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Zomedica EPS forecast chart

Profile Summary

Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
January 7th, 2013
Public Since
October 28th, 2013
No. of Employees
144
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
us flag iconNYSE MKT
Shares in Issue
979,949,668

ZOM Share Price Performance

Upcoming Events for ZOM

Zomedica Corp at Lytham Spring Investor Conference (Virtual)

Zomedica Corp Annual Shareholders Meeting

Zomedica Corp Annual Shareholders Meeting

Q2 2024 Zomedica Corp Earnings Release

Q3 2024 Zomedica Corp Earnings Release

Similar to ZOM

FAQ